Skip to main content
CADL
NASDAQ Life Sciences

Shares Sink 38% After-Hours as Candel Updates Application Timing

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$5.11
Mkt Cap
$641.991M
52W Low
$4.35
52W High
$14
52W Position info
17% above low
Off High info
63% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

CADL sits 17% above its 52-week low of $4.35.

Summary

Candel fell 38% in after-hours trading Thursday after an update on application timing, with shares closing the regular session at $8.39, down 9%. The company also started the first site in its Phase 3 AURORA trial, testing aglatimagene plus valacyclovir and pembrolizumab against docetaxel in metastatic non-squamous lung cancer. On Nov. 12, 2026, Candel amended its sale agreement with Jefferies, allowing it to offer up to $50 million in common stock. The timing update is the driver here: it lands the day after the Q3 8-K disclosed a widened $21.9 million net loss and a mid-2027 BLA submission target, so any perceived slippage in that timeline hits a stock already digesting higher R&D spend. The fresh $50 million ATM adds dilution overhang on top of the selloff.

At the time of this announcement, CADL was trading at $5.11 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $642M. The 52-week trading range was $4.35 to $14.00. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CADL - Latest Insights

CADL
Nov 12, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.39
Real-time Price: $6.00 info
Change: -$2.39 (-28%) info
Market Cap: $474.415M info
CADL
Nov 12, 2026, 4:05 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $8.39
Real-time Price: $6.00 info
Change: -$2.39 (-28%) info
Market Cap: $474.415M info
CADL
Oct 01, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $10.40
Real-time Price: $6.00 info
Change: -$4.40 (-42%) info
Market Cap: $474.415M info
CADL
Sep 30, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $10.96
Real-time Price: $6.00 info
Change: -$4.96 (-45%) info
Market Cap: $474.415M info
CADL
Sep 09, 2026, 4:50 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.14
Real-time Price: $6.00 info
Change: -$6.14 (-51%) info
Market Cap: $474.415M info